Literature DB >> 15934972

Is there a place for duplex screening of the brachial artery in the maturation of arteriovenous fistulas?

Carlo Lomonte1, Francesco Casucci, Maurizio Antonelli, Bernardo Giammaria, Nicola Losurdo, Giovanni Marchio, Carlo Basile.   

Abstract

Clinically there are some autogenous arteriovenous fistulas (AVFs) that are obviously mature. The real problem in clinical evaluation is in predicting the ultimate outcome of AVFs that are not clearly mature. Thus it would be advantageous to develop objective quantitative criteria to be applied early after vascular access placement in order to evaluate the suitability of AVFs for dialysis. The goal of this study was to document the blood flow rate modifications that the construction and maturation of a radiocephalic wrist AVF produce in the brachial artery by means of duplex Doppler ultrasonography. All incident uremic patients who needed the construction of a radiocephalic wrist AVF in the last 9 months of 2003 were enrolled in the study: 18 patients underwent such an operation. A linear color Doppler ultrasound scan was performed with a 7.0 MHz imaging/5.0 MHz Doppler probe by sampling the brachial artery 2 cm above the elbow: the internal diameter of the artery was measured and its blood flow rate calculated just before AVF construction and 1, 7, 28 days, and at least 6 months after AVF construction. The internal diameter and blood flow rate of the brachial artery were, respectively, 4.3 +/- 0.7 mm and 56.1 +/- 19.2 ml/min at baseline. A new AVF was constructed in one patient whose brachial artery blood flow rate was 80.0 ml/min at 28 days. When excluding this AVF, the mean brachial artery blood flow rate of the 17 AVFs was 720.4 +/- 132.8 ml/min (median 750 ml/min, range 480-890 ml/min) at 28 days and 997.6 +/- 259.7 ml/min 258.0 +/- 63.0 days after AVF construction. When analyzing the percent increase in brachial artery blood flow rate of the 17 AVFs at the different time points, the most dramatic one occurred at day 1 compared to the baseline (549.0%; mean blood flow rate at day 1, 365.0 +/- 129.3 ml/min). Thus the blood flow rate at day 1 represents more than half (50.7%) of the blood flow rate that will be measured at day 28. Then the increase was less steep, with a 20.1% increase between day 7 and day 1 (mean blood flow rate at day 7, 438.4 +/- 86.0 ml/min), a 64.3% increase between day 28 and day 7, and a 38.5% increase at 258.0 +/- 63.0 days compared to 28 days. The present study was able to document the changes in brachial blood flow rate consequent to a radiocephalic wrist AVF maturation by means of duplex Doppler ultrasonography of the brachial artery. This measure may be helpful in monitoring which AVFs will probably fail. This screening should integrate clinical assessment, thus allowing sound judgment of the level of maturation of an AVF and of its outcome.

Entities:  

Mesh:

Year:  2005        PMID: 15934972     DOI: 10.1111/j.1525-139X.2005.18320.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  16 in total

Review 1.  Color Doppler ultrasound and arteriovenous fistulas for hemodialysis.

Authors:  Pasquale Zamboli; Fulvio Fiorini; Alessandro D'Amelio; Pasquale Fatuzzo; Antonio Granata
Journal:  J Ultrasound       Date:  2014-07-11

Review 2.  Impaired maturation of distal radio-cephalic fistula for haemodialysis: a review of treatment options.

Authors:  Nicola Pirozzi; Jose Garcia Medina; Paolo Menè
Journal:  J Nephrol       Date:  2016-07-07       Impact factor: 3.902

3.  Arteriovenous Fistula Development in the First 6 Weeks after Creation.

Authors:  Michelle L Robbin; Tom Greene; Alfred K Cheung; Michael Allon; Scott A Berceli; James S Kaufman; Matthew Allen; Peter B Imrey; Milena K Radeva; Yan-Ting Shiu; Heidi R Umphrey; Carlton J Young
Journal:  Radiology       Date:  2015-12-22       Impact factor: 11.105

4.  Surveillance of hemodialysis vascular access.

Authors:  William L Whittier
Journal:  Semin Intervent Radiol       Date:  2009-06       Impact factor: 1.513

5.  A Predictive Framework to Elucidate Venous Stenosis: CFD & Shape Optimization.

Authors:  S M Javid Mahmoudzadeh Akherat; Kevin Cassel; Michael Boghosian; Mary Hammes; Fredric Coe
Journal:  Comput Methods Appl Mech Eng       Date:  2017-04-10       Impact factor: 6.756

Review 6.  Definitions and End Points for Interventional Studies for Arteriovenous Dialysis Access.

Authors:  Gerald A Beathard; Charmaine E Lok; Marc H Glickman; Ahmed A Al-Jaishi; Donna Bednarski; David L Cull; Jeffery H Lawson; Timmy C Lee; Vandana D Niyyar; Donna Syracuse; Scott O Trerotola; Prabir Roy-Chaudhury; Surendra Shenoy; Margo Underwood; Haimanot Wasse; Karen Woo; Theodore H Yuo; Thomas S Huber
Journal:  Clin J Am Soc Nephrol       Date:  2017-07-20       Impact factor: 8.237

Review 7.  Quality indicators of vascular access procedures for hemodialysis.

Authors:  Branko Fila
Journal:  Int Urol Nephrol       Date:  2020-08-31       Impact factor: 2.370

8.  Accuracy of volumetric flow rate measurements: an in vitro study using modern ultrasound scanners.

Authors:  Kenneth Hoyt; Felix A Hester; Randall L Bell; Mark E Lockhart; Michelle L Robbin
Journal:  J Ultrasound Med       Date:  2009-11       Impact factor: 2.153

9.  Prediction of Arteriovenous Fistula Clinical Maturation from Postoperative Ultrasound Measurements: Findings from the Hemodialysis Fistula Maturation Study.

Authors:  Michelle L Robbin; Tom Greene; Michael Allon; Laura M Dember; Peter B Imrey; Alfred K Cheung; Jonathan Himmelfarb; Thomas S Huber; James S Kaufman; Milena K Radeva; Prabir Roy-Chaudhury; Yan-Ting Shiu; Miguel A Vazquez; Heidi R Umphrey; Lauren Alexander; Carl Abts; Gerald J Beck; John W Kusek; Harold I Feldman
Journal:  J Am Soc Nephrol       Date:  2018-10-11       Impact factor: 10.121

10.  Vascular remodeling in autogenous arterio-venous fistulas by MRI and CFD.

Authors:  Monica Sigovan; Vitaliy Rayz; Warren Gasper; Hugh F Alley; Christopher D Owens; David Saloner
Journal:  Ann Biomed Eng       Date:  2012-11-27       Impact factor: 3.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.